fbpx

Day

December 18, 2014
Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it has filed an action in federal district court for the District of Columbia against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus® XR.
Trial using Nexstim's Navigated Brain Therapy (NBT®) system for pain relief in patients suffering from chronicneuropathic painSecond study using Nexstim's technology at The Walton Centre, the only specialist neuroscience centre in the NHS, to show long term effect of NBT®Previous study demonstrated 44% of patients obtained clinically meaningful pain relief of at least 3 weeks'...

News

Eske Willerslev receives prestigious Norwegian science prize for his Lundbeck Foundation research on brain disorders
22. January 2021
Science Programme Director (Open Neuroplatform)
18. January 2021
Scientific Programme Director (Talent programs)
15. January 2021

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge